The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Postnatal Serum Insulin-Like Growth Factor I Deficiency Is Associated With Retinopathy of Prematurity and Other Complications of Premature Birth
Abstract
Objective. Insulin-like growth factor I (IGF-I) is necessary for normal development of retinal blood vessels in mice and humans. Because retinopathy of prematurity (ROP) is initiated by abnormal postnatal retinal development, we hypothesized that prolonged low IGF-I in premature infants might be a risk factor for ROP. Design. We conducted a prospective, longitudinal study measuring serum IGF-I concentrations weekly in 84 premature infants from birth (postmenstrual ages: 24–32 weeks) until discharge from the hospital. Infants were evaluated for ROP and other morbidity of prematurity: bronchopulmonary dysplasia (BPD), intraventricular hemorrhage (IVH), and necrotizing enterocolitis (NEC). Results. Low serum IGF-I values correlated with later development of ROP. The mean IGF-I ± SEM level during postmenstrual ages 30–33 weeks was lowest with severe ROP (25 ± 2.41 μg/L), 29 ± 1.76 μg/L with moderate ROP, and 33 ± 1.72 μg/L with no ROP. The duration of low IGF-I also correlated strongly with the severity of ROP. The interval from birth until serum IGF-I levels reached >33 μg/L was 23 ± 2.6 days for no ROP, 44 ± 4.8 days for moderate ROP, and 52 ± 7.5 days for severe ROP. Each adjusted stepwise increase of 5 μg/L in mean IGF-I during postmenstrual ages 30 to 33 weeks decreased the risk of proliferative ROP by 45%. Other complications (NEC, BPD, IVH) were correlated with ROP and with low IGF-I levels. The relative risk for any morbidity (ROP, BPD, IVH, or NEC) was increased 2.2-fold (95% confidence interval: 1.41–3.43) if IGF-I was ≤33 μg/L at 33 weeks’ postmenstrual age. Conclusions. These results indicate that persistent low serum concentrations of IGF-I after premature birth are associated with later development of ROP and other complications of prematurity. IGF-I is at least as strong a determinant of risk for ROP as postmenstrual age at birth and birth weight.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of insulin-like growth factors in embryonic and postnatal growth
Baker, J., Liu, J.-P., Robertson, E. J., & Efstratiadis, A. (1993) · Cell · doi:10.1016/s0092-8674(05)80085-6 · Cited by 2,463
Shennan, A. T., Dunn, M. S., Ohlsson, A., Lennox, K., & Hoskins, E. M. (1988) · Pediatrics · doi:10.1542/peds.82.4.527 · Cited by 1,254
Hellstrom, A., Perruzzi, C., Ju, M., Engström, E., Hård, A.-L., Liu, J.-L., Albertsson-Wikland, K., Carlsson, B., Niklasson, A., Sjödell, L., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.101113998 · Cited by 583
Self-citationSmith, L. E. H., Shen, W., Perruzzi, C., Soker, S., Kinose, F., Xu, X., Robinson, G., Driver, S., Bischoff, J., Zhang, B., et al. (1999) · Nature Medicine · doi:10.1038/70963 · Cited by 556
Self-citationGrowth Enhancement of Transgenic Mice Expressing Human Insulin-Like Growth Factor I*
MATHEWS, L. S., HAMMER, R. E., BEHRINGER, R. R., D'ERCOLE, A. J., BELL, G. I., BRINSTER, R. L., & PALMITER, R. D. (1988) · Endocrinology · doi:10.1210/endo-123-6-2827 · Cited by 477
Essential Role of Growth Hormone in Ischemia-Induced Retinal Neovascularization
Smith, L. E. H., Kopchick, J. J., Chen, W., Knapp, J., Kinose, F., Daley, D., Foley, E., Smith, R. G., & Schaeffer, J. M. (1997) · Science · doi:10.1126/science.276.5319.1706 · Cited by 393
Self-citationGiudice, L. C. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.5.1548 · Cited by 383
Radioimmunoassays for IGFs and IGFBPs.
Blum, W. F. P., & Breier, B. H. (1994) · PubMed · Cited by 362
Human Embryology and Teratology
O’Rahilly, R. (1990) · Cited by 291
Fetal growth and placental function
Bauer, M. K., Harding, J. E., Bassett, N. S., Breier, B. H., Oliver, M. H., Gallaher, B. H., Evans, P. C., Woodall, S. M., & Gluckman, P. D. (1998) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(98)00039-2 · Cited by 231
Cited by
Hellström, A., Smith, L. E., & Dammann, O. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60178-6 · Cited by 1,304
Self-citationRetinopathy of prematurity: a review of risk factors and their clinical significance
Kim, S. J., Port, A. D., Swan, R., Campbell, J. P., Chan, R. V. P., & Chiang, M. F. (2018) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2018.04.002 · Cited by 579
Early Insulin Therapy in Very-Low-Birth-Weight Infants
Beardsall, K., Vanhaesebrouck, S., Ogilvy-Stuart, A. L., Vanhole, C., Palmer, C. R., van Weissenbruch, M., Midgley, P., Thompson, M., Thio, M., Cornette, L., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0803725 · Cited by 310
Pathogenesis of retinopathy of prematurity
Smith, L. E. H. (2003) · Seminars in Neonatology · doi:10.1016/s1084-2756(03)00119-2 · Cited by 295
Self-citationLöfqvist, C. (2006) · Archives of Ophthalmology · doi:10.1001/archopht.124.12.1711 · Cited by 291
Metadata
- Authors
- Hellström, A., Engström, E., Hård, A.-L., Albertsson-Wikland, K., Carlsson, B., Niklasson, A., Löfqvist, C., Svensson, E., Holm, S., Ewald, U., Holmström, G., & Smith, L. E. H.
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2003-11-01
- Volume
- 112
- Issue
- 5
- Pages
- 1016-1020
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W2064147974
- Cited by
- 526
- References
- 16
- FWCI
- 13.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Postnatal Serum Insulin-Like Growth Factor I Deficiency Is Associated With Retinopathy of Prematurity and Other Complications of Premature Birth. https://app.cochat.ai/papers/10.1542/peds.112.5.1016
- The paper
- Hellström, A., Engström, E., Hård, A.-L., Albertsson-Wikland, K., Carlsson, B., Niklasson, A., Löfqvist, C., Svensson, E., Holm, S., Ewald, U., Holmström, G., & Smith, L. E. H. (2003). Postnatal Serum Insulin-Like Growth Factor I Deficiency Is Associated With Retinopathy of Prematurity and Other Complications of Premature Birth. Pediatrics. https://doi.org/10.1542/peds.112.5.1016
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.